patent/JP-2021095409-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021095409-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate	2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d81ecddbe7208135f936d36481f1556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_039d80acc3663760b4661edaef1f242a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e51217ebd5a4dc059d75f8b6d23e697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1009bf3c3184381e0af022779a5775cc
publicationDate	2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-2021095409-A
titleOfInvention	Use of linagliptin in cardioprotective and renal protective antidiabetes treatment
abstract	PROBLEM TO BE SOLVED: To provide an effective, safe and tolerant antidiabetes therapeutic agent. The present invention relates to the DPP-4 inhibitor linagliptin for use in the treatment of cardioprotection and / or renal protection in diabetic or non-diabetic patients at high vascular risk. [Selection diagram] None
priorityDate	2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012065993-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21947621 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11647687 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414306796 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25188410 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419869871 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422980837

Total number of triples: 46.